Inflexion Private Equity, a leading UK-based private equity firm, has recently announced its acquisition of Proteros, a German biotechnology company that specializes in protein crystallography and drug discovery services. This acquisition marks Inflexion’s latest expansion into the healthcare sector, as the firm seeks to capitalize on the growing demand for innovative healthcare solutions.
Proteros was founded in 1999 and has since established itself as a leading provider of protein crystallography services, which are used to determine the three-dimensional structure of proteins. This information is critical in drug discovery, as it allows researchers to design drugs that can interact with specific proteins in the body. Proteros also offers a range of other drug discovery services, including assay development, hit identification, and lead optimization.
Inflexion’s acquisition of Proteros is part of the firm’s broader strategy to invest in companies that are driving innovation in the healthcare sector. In recent years, healthcare has become an increasingly attractive area for private equity firms, as advances in technology and changing demographics have created new opportunities for growth and investment.
According to Inflexion’s Managing Partner, Simon Turner, “Proteros is a highly innovative company with a strong track record of delivering cutting-edge drug discovery services. We believe that their expertise in protein crystallography and other areas of drug discovery will be a valuable addition to our healthcare portfolio.”
Inflexion’s healthcare portfolio already includes several other companies that are focused on developing innovative healthcare solutions. These include Xtracare, a provider of home healthcare services, and Aspen Healthcare, a private hospital group that operates several hospitals in the UK.
The acquisition of Proteros is expected to further strengthen Inflexion’s position in the healthcare sector and provide the firm with new opportunities for growth and investment. As the demand for innovative healthcare solutions continues to grow, private equity firms like Inflexion are likely to play an increasingly important role in driving innovation and growth in the industry.
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- Minting the Future w Adryenn Ashley. Access Here.
- Source: Plato Data Intelligence: PlatoData
The Journey of Funds: From the Barrel to the Bank – Insights from PE Hub
The Journey of Funds: From the Barrel to the Bank – Insights from PE Hub Private equity (PE) has become...